This year 2023 has ushered in an era when many new R&D technologies in the CGT industry are flourishing. It is predicted that the future global CGT market will still maintain a rapid growth trend. To fast track the R&D technologies in the CGT industry and bring you insights to develop your next-generation Cell and Gene therapeutics, Biomap is proud to announce the BioCon Asia – ACGT taking place on the 12th – 13th October 2023.

BioCon is a series of conferences and exhibitions that have grown to become the largest and most established biopharmaceutical meetings of its kind across China and worldwide. As part of the series, BioCon Asia-ACGT is set to bring together prominent leaders and scientists across the world to share innovative discoveries, new case studies, clinical data and business prospect in the CGT industry.

This conference will focus on the most promising development trends in the CGT industry. You will get the chance to hear how the UCAR-T products are developed to treat diseases and how to advance different cell therapies such as CAR-T, TCR-T, In Vivo Cell Therapy to find solutions for solid tumors. As for the gene therapy, there is a significant focus on AAV-based vector innovation and optimization, as well as the new delivery tool-LNP for gene therapy. In addition, the cutting-edge gene editing techniques will also become a major topic in our conference.

We look forward to welcoming you to the event in Singapore this September to create ground-breaking, life-saving cell and gene therapies for patients with unmet medical need.